Rosetta Genomics to Present Advancements in Its Cup Diagnostic Development Program
April 12, 2007 08:30 ET
|
Rosetta Genomics, Ltd.
NEW BRUNSWICK, N.J. and REHOVOT, Israel, April 12, 2007 (PRIME NEWSWIRE) -- Rosetta Genomics, Ltd. (Nasdaq:ROSG), announced today that it will present updated results on its lead diagnostic...
Rosetta Genomics Announces the Development of a Proprietary MicroRNA Extraction Protocol From Blood Serum as Well as Advancements in Its Diagnostic and Therapeutic Development Programs At Cambridge Healthtech Institute's MicroRNA in Human Disease and Development Conference
April 02, 2007 14:03 ET
|
Rosetta Genomics, Ltd.
REHOVOT, Israel , April 2, 2007 (PRIME NEWSWIRE) -- Rosetta Genomics, Ltd. (Nasdaq:ROSG) announced today that it has presented data on its newly developed high quality microRNA extraction protocol...
Rosetta Genomics to Present Advancements in Its Diagnostic and Therapeutic Development Programs At Cambridge Healthtech Institute's Microrna in Human Disease and Development Conference
March 28, 2007 10:08 ET
|
Rosetta Genomics, Ltd.
REHOVOT, Israel, March 28, 2007 (PRIME NEWSWIRE) -- Rosetta Genomics, Ltd. (Nasdaq:ROSG) announced today that Dr. Dalia Cohen, the company's Global Head of Research and Development, will be presenting...
Rosetta Genomics Reports Fourth Quarter and 2006 Financial Results
March 27, 2007 08:00 ET
|
Rosetta Genomics, Ltd.
NEW BRUNSWICK, N.J. and REHOVOT, Israel, March 27, 2007 (PRIME NEWSWIRE) -- Rosetta Genomics (Nasdaq:ROSG), today reported its consolidated financial results for the fourth quarter and year ended...